PAINCEPTOR PHARMA CORPORATION

PainCeptor Pharma Corporation is a Canadian-based, private biopharmaceutical company focused on the development of safe, effective and peripherally-active drugs to treat pain. PainCeptor Pharma is a pharmaceutical company that specializes in creating innovative drugs for the treatment of chronic and acute pain. The company's focus is on developing therapies that target specific receptors within the peripheral nervous system (PNS) in order to improve efficacy and minimize the negative side effects commonly associated with traditional pain medications, which primarily act on the central nervous system (CNS). PainCeptor has a robust pipeline of potential therapeutic drugs, including lead programs targeting NGF/p75-TrkA, ASIC1a, and ASIC3. PainCeptor Pharma was founded in 2004.